EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 2 (Février 2004) Med Sci (Paris), 20 2 (2004) 169-174 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 2, Février 2004
Page(s) 169 - 174
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004202169
Published online 15 February 2004
  1. Capron L. Étiologie de l’athérosclérose. Rev Prat 1999; 49 : 2 100–3. [Google Scholar]
  2. Nieto FJ. Infections and atherosclerosis : new clues from an old hypothesis ? Am J Epidemiol 1998; 148 : 937–48. [Google Scholar]
  3. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148 : 335–40. [Google Scholar]
  4. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2 : 983–5. [Google Scholar]
  5. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis : critical assessment of diagnostic methods and relevance to treatment strategies. Clin Microb Rev 2002; 15 : 1–20. [Google Scholar]
  6. Mendall M, Goggin P, Levy J, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71 : 437–9. [Google Scholar]
  7. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96 : 404–7. [Google Scholar]
  8. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomised trial of roxithromycin in non-Q wave coronary syndromes : ROXIS pilot study. Lancet 1997; 350 : 404–7. [Google Scholar]
  9. Epstein SE, Zhu JH, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis : potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000; 20 : 1 417–20. [Google Scholar]
  10. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. JAMA 2000; 284 : 1 406–10. [Google Scholar]
  11. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105 : 15–21. [Google Scholar]
  12. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. Br Med J 2000; 321 : 208–12. [Google Scholar]
  13. Smieja M, Chong S, Natarajan M, et al. Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography. J Clin Microbiol 2001; 39 : 596–600. [Google Scholar]
  14. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease : is there a link ? Lancet 1997; 350 : 430–6. [Google Scholar]
  15. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001; 32 : 385–90. [Google Scholar]
  16. Farsak B, Yildirir A, Akyon Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000; 38 : 4408–11. [Google Scholar]
  17. Capron L. Chlamydia in coronary plaques : Hidden culprit or harmless hobo ? Nat Med 1996; 2 : 856–7. [Google Scholar]
  18. Fabricant CG. Atherosclerosis : the consequence of infection with a herpesvirus. Adv Vet Sci Comp Med 1985; 30 : 39–66. [Google Scholar]
  19. Capron L. How to design vaccination trials to prevent atherosclerosis. Am Heart J 1999; 138 : S558–9. [Google Scholar]
  20. Morré SA, Stooker W, Lagrand WK, van den Brule AJC, Niessen HWM. Microorganisms in the aetiology of atherosclerosis. J Clin Pathol 2000; 53 : 647–54. [Google Scholar]
  21. Gaydos CA. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 2000; 181 : S473–8. [Google Scholar]
  22. Stone AFM, Mendall MA, Kaski JC, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes : South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002; 106 : 1 219–23. [Google Scholar]
  23. Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur Heart J 1999; 20 : 89–92. [Google Scholar]
  24. Sinisalo J, Mattila K, Valtonen V, et al. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndromes. Circulation 2002; 105 : 1 555–60. [Google Scholar]
  25. Cercek B. Azithromycin in acute coronary syndrome investigators. The effect of short-term treatment with azithromycin on recurrent ischemic events in patients with acute coronary syndrome. Program and abstracts of the American College of Cardiology, 51st Annual Meeting, March 17-20, 2002. Atlanta, Georgia : American College of Cardiology, 2002 (abstract 405-3). [Google Scholar]
  26. Muhlestein JB, Anderson JL, Carlquist JF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Primary clinical results of the ACADEMIC study. Circulation 2000; 102 : 1755–60. [Google Scholar]
  27. Neumann FJ, Kastrati A, Miethke T, et al. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3) : a randomised, double-blind, placebo-controlled trial. Lancet 2001; 357 : 2 085–9. [Google Scholar]
  28. Dunne M, O’Connor C, Pfeffer M, Muhlestein B, Gupta S, Yao L. Weekly intervention with zithromax for atherosclerosis and its related disorders (the WIZARD Study). Program and abstracts of the American College of Cardiology, 51st Annual Meeting, March 17-20, 2002. Atlanta, Georgia : American College of Cardiology, 2002 (abstract 405-4). [Google Scholar]
  29. Gieffers J, Solbach W, Maass M. In vitro susceptibilities of Chlamydia pneumoniae strains recovered form atherosclerotic coronary arteries. Antimicrob Agents Chemother 1998; 42 : 2762–4. [Google Scholar]
  30. Schneider C, Diedrich H, Riedel KD, et al. In vivo uptake of azithromycin in human coronary plaque. Am J Cardiol 2000; 86 : 789–91. [Google Scholar]
  31. Beatty W, Morrison R, Byrne G. Persistent Chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58 : 686–99. [Google Scholar]
  32. Gieffers J, Füllgraf H, Jahn J, et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001; 103 : 351–6. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.